Sylvester Comprehensive Cancer Center researcher Priyamvada Rai, Ph.D., has been appointed to the Tumor Cell Biology Study Section of the Center for Scientific Review at the National Institutes of Health. Being named a member of the study section is a distinct honor and “a unique opportunity to contribute to the national biomedical research effort,” the director of the Center for Scientific Review said in his letter to Rai.
Sylvester Researchers Identify Protein that Triggers Virus-Mediated Chronic Inflammation and Cancers 04.25.2018
Viruses are linked to approximately 12 percent of all cancers and are associated with chronic inflammation. Sylvester Comprehensive Cancer Center researchers Noula Shembade, Ph.D., Richard Hunte and colleagues honed in on what activates that process. They found the human protein CADM1 interacts with Kaposi’s sarcoma viral proteins and promotes inflammation that can result in development of certain cancers.
In addition to hours of class work, clinical training, and endless amounts of studying, medical students also face the challenge of focusing in on which medical specialty they would like to pursue. The Office of Student Services tries to make that task a little easier each year by hosting numerous events, including the annual Career Advising Dinner.
Investigating the microbiome has provided new insights into infection control, metabolism and mental health. It may also play a significant and surprising role in cancer. Scientists at Sylvester Comprehensive Cancer Center have shown that depleting the gut microbiome reduces tumor growth and metastases in models of pancreatic cancer and melanoma and slows metastases in colon cancer.
Patients who participate in Phase 1 clinical trials at Sylvester Comprehensive Cancer Center now have a new clinic where they can get their specialized care in one convenient location. On Friday, April 20, Sylvester’s director, Stephen D. Nimer, M.D., and the director of Phase 1 clinical trials, Jaime Merchan, M.D., cut the ribbon at the new clinic located on the third floor.
Antibody ‘Cocktail’ Can Prevent Zika Infection But Is Not Effective for Treatment of Fetuses, Say Miller School Researchers 04.24.2018
A “cocktail” of monoclonal antibodies that can prevent Zika virus (ZIKV) infection in primates was not effective for treatment of fetuses, according to a new collaborative study led by a University of Miami Miller School of Medicine research team. The team is now working on engineering the antibodies to redirect the therapies to the fetus.
A pair of Miller School students took home the Grand Prize in the Graduate/Alumni Track — and a check for $10,000 — in the 2018 University of Miami Business Plan Competition, sponsored by the UM Business School. They also walked away with a separate check for $1,500 for the Best Presentation in the Graduate/Alumni Track. The competition’s final presentations and award ceremony took place on April 11.
UHealth Surgeons Perform Double Lung Transplant on Singer José Luis Rodriguez, Known as ‘El Puma’ 04.20.2018
Surgeons with UHealth – the University of Miami Health System successfully performed a double lung transplant on Venezuelan-born artist José Luis Rodriguez, known as “El Puma.” The beloved singer shared his story at an April 20 news conference as part of April’s “National Donate Life Month” observance.
A select group of medical, graduate and M.D./Ph.D. students and resident physicians at the University of Miami Miller School of Medicine had the opportunity to present their work and network with dozens of student peers and academic professionals at the 2018 Eastern-Atlantic Student Research Forum (ESRF).
Longtime philanthropists Robert M. Cornfeld, D.M.D., and his wife, Judith, recently made a $4 million donation to the Department of Neurology at the University of Miami Miller School of Medicine to create the Judy and Robert Cornfeld Neuro-Imaging Research Center. The center will be a multidisciplinary research environment, using advanced imaging to understand brain function and memory.